|
Recent Developments |
|
04-OCT-13
Aarey Drugs & Pharmaceuticals, a manufacturer of pharmaceutical bulk drugs, climbed on Friday after its board approved the proposal for demerger of part of petrochemical business into Enam Organics India.
03-OCT-13
Aarey Drugs & Pharmaceuticals announced that the board of directors has approved the proposal for demerger of part of petrochemical business into Enam Organics India.
30-MAY-13
Aarey Drugs & Pharmaceuticals said its net l... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 30-Sep-2016(6) | 31-Mar-2016(12) | 31-Mar-2015(12) | | Net sales | 1770.17 | 2460.30 | 2134.41 | | Other Income | 7.91 | 31.37 | 25.92 | | Total Income | 1778.08 | 2491.67 | 2160.33 | | Cost of goods sold | 802.99 | 2451.46 | 2123.39 | | OPBDIT | 975.09 | 40.21 | 36.94 | | PAT | 27.85 | 12.90 | 10.88 | | Gross Block | - | - | - | | Equity capital | 175.80 | 168.15 | 168.15 | | EPS (Rs.) | - | - | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 54.8 | 1.6 | 1.7 | | Net margin (% of OI) | 1.6 | 0.5 | 0.5 |
|
|
Detailed Financials
|
|
|
|
|
